Results 291 to 300 of about 84,264 (300)

6-Nitrobenzimidazole derivatives: Potential phosphodiesterase inhibitors: Synthesis and structure–activity relationship

Bioorganic and Medicinal Chemistry, 2012
Zarbad Shah, Nida Ambreen, M Iqbal Iqbal Choudhary   +2 more
exaly  

A comprehensive review on the potential therapeutic benefits of phosphodiesterase inhibitors on cardiovascular diseases

Biomedicine and Pharmacotherapy, 2017
Reza Shafiee-Nick, Amir R Afshari, Seyed Hadi Mousavi   +2 more
exaly  

Recreational Use and Misuse of Phosphodiesterase 5 Inhibitors

Journal of the American Pharmacists Association: JAPhA, 2005
Frank Romanelli
exaly  

Pharmacological and biochemical study on the effects of selective phosphodiesterase inhibitors on human term myometrium

Naunyn-Schmiedeberg's Archives of Pharmacology, 1999
Marc Bardou, Catherine Deneux-tharaux, Esteban Morcillo   +2 more
exaly  

Synergistic interactions between selective pharmacological inhibitors of phosphodiesterase isozyme families PDE III and PDE IV to attenuate proliferation of rat vascular smooth muscle cells

Biochemical Pharmacology, 1994
exaly  

1-(2-(2,2,2-Trifluoroethoxy)ethyl-1H-pyrazolo[4,3-d]pyrimidines as potent phosphodiesterase 5 (PDE5) inhibitors

Bioorganic and Medicinal Chemistry Letters, 2010
John K Walker
exaly  

Phosphodiesterase Inhibitors

2014
openaire   +2 more sources

Phosphodiesterase 5 inhibitors: current status and potential applications

Nature Reviews Drug Discovery, 2002
exaly  

Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors

Neuropharmacology, 1983
exaly  

Phosphodiesterase inhibitors.

British journal of hospital medicine, 1989
openaire   +1 more source